| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -59.9% |
| Cost of Revenue | $15.3M | +75.4% |
| Gross Profit | -$13.9M | -172.5% |
| R&D Expense | $26.2M | -30.5% |
| SG&A Expense | $25.2M | -31.4% |
| Operating Income | -$87.8M | +11.2% |
| Income Tax | $57K | -1.7% |
| Net Income | -$87.1M | +11.7% |
| EPS (Basic) | -$14.95 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.9M | -11.2% |
| Accounts Receivable | $131K | -78.8% |
| Inventory | $583K | -87.2% |
| Current Assets | $39.8M | -62.3% |
| Total Assets | $54.3M | -59.3% |
| Current Liabilities | $10.0M | -55.6% |
| Total Liabilities | $25.3M | -35.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.7M | +29.2% |
| Capital Expenditures | $2.0M | -53.5% |
| Investing Cash Flow | $55.4M | -19.2% |
| Financing Cash Flow | -$6.8M | -183.8% |
| Free Cash Flow | -$52.7M | +30.6% |
| -2273.0% |
| EPS (Diluted) | -$14.95 | -2273.0% |
| Stockholders' Equity |
| $29.0M |
| -69.1% |